20245 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
Extracts from for the treatment of hyperglycemia and hypertension
#902NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE
#903Lyophilization of synthetic liposomal pulmonary surfactant
#904Lyophilization of synthetic liposomal pulmonary surfactant
#905TOPICAL COMPOSITIONS AND METHODS OF USE
#906Methods of treating muscular dystrophy
#907METHOD FOR TREATING MACULAR DEGENERATION
#908VAGINAL COMPOSITIONS BASED ON ALKYL POLYGLUCOSIDES
#909Impaired energy processing disorders and mitochondrial deficiency
#910Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits
#911NUTRITIONAL COMPOSITIONS INCLUDING BRANCHED CHAIN FATTY ACIDS AND METHODS OF USING SAME
#912Compositions and methods for the prevention of cardiovascular disease
#913Antifungal serum
#914KETOGENIC DIET COMPOSITION FOR THE TREATMENT OF CHEMO THERAPY AND/OR RADIATION THERAPY PATIENTS
#915Bioeffective krill oil compositions
#916Methods for producing bioeffective krill oil compositions
#917Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#918Eukaryotic microorganisms for producing lipids and antioxidants
#919Combination of Components for the Prevention and Treatment of Frailty
#920Non-medical increase or maintenance of body weight of a mammal
#921COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
#922Substance for preventing and improving arthritis
#923Methods and compositions for treating, reducing or preventing deterioration of the visual system of animals
#924Therapeutic use of compounds
#925COMPOSITIONS CONTAINING HIGH OMEGA-3 AND LOW SATURATED FATTY ACID LEVELS
#926Monounsaturated fatty acid for preventing and/or treating skin complexion imperfections
#927FATTY ACID TREATMENT FOR CARDIAC PATIENTS
#928Composition for improving membrane composition and functioning of cells
#929Use of at least one coproduct from the vegetable oil refining industry for obtaining a purified total unsaponifiable vegetable oil product
#930Pet food compositions and methods for weight loss and maintenance
#931Myelin Sheath Fatty Acids that Resolve Neuroinflammation
#932Chemosensory Receptor Ligand-Based Therapies
#933Pet food compositions and methods for treating arthritis and inflammation associated with arthritis
#934Use of trans-palmitoleate in identifying and treating metabolic disease
#935Compounds, compositions and methods useful for cholesterol mobilization
#936Pheromone compositions and methods of use
#937Satiety-inducing composition
#938Compounds and Pharmaceutical Compositions for Uses in Diabetes
#939Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
#940Lipid delivery formulations
#941ALCOHOLIC EXTRACT OF FUNGI OF GENUS CUNNINGHAMELLA AND USE THEREOF
#942Thermally stable oil-in-water emulsions containing an oil that contains polyunsaturated fatty acids
#943Tube feed packages and methods for using same
#944Tube feed formulations and methods for using same
#945AGENT AND METHOD FOR STABILIZING MEMBRANE PROTEIN
#946NUTRIENT SENSOR
#947Hernia patch
#948Preparation for the prevention and/or treatment of vascular disorders
#949Stable high lipid liquid formula
#950MIR27B is a novel target for treatment of liver fibrosis
#951Functional, cross-linked nanostructures for tandem optical imaging and therapy
#952Fatty acids for use as a medicament
#953FIVE AND FIFTEEN CARBON FATTY ACIDS FOR TREATING METABOLIC DISORDERS AND AS NUTRITIONAL SUPPLEMENTS
#954Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
#955N-acyl amino acid derivatives for treating skin conditions such as cellulite
#956Treatment of degenerative joint disease
#957Compositions, kits and methods for nutrition supplementation
#958Treatment of prolonged status epilepticus
#959Compositions comprising avermectin/azelaic acid compounds useful for treating e.g., rosacea
#960Nitrated-fatty acids modulation of type II diabetes
#961Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
#962Abuse-deterrent pharmaceutical compositions of opiods and other drugs
#963COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
#964Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
#965Feed supplement comprising oligosaccharides and medium chain fatty acids
#966Glycogen or polysaccharide storage disease treatment method
#967Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#968OIL COMPOSITIONS
#969DIETARY CONTROL OF ARACHIDONIC ACID METABOLISM
#970METHODS FOR IMPROVING BLOOD GLUCOSE CONTROL
#971Methods of treating inflammatory conditions
#972NOVEL COCHLEATE FORMULATIONS
#973Antimicrobial Compositions Containing Free Fatty Acids
#974KIT FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
#975NUTRITIVE COMPOSITIONS AND METHODS OF USING SAME
#976Agent having neurotrophic factor-like activity
#977Polypeptoid pulmonary surfactants
#978COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF
#979Biologically active oils
#980Coated Tablets, Their Method of Preparation, and Related Uses
#981Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
#982Hydroxyl compounds and compositions for cholesterol management and related uses
#983Antimicrobial and antiviral composition
#984NUTRITIONAL SUPPLEMENT FOR PATIENTS WITH CHRONIC HEART FAILURE
#985Treatment of urinary incontinence using nitrone spin traps
#986SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS IN HUMANS
#987METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
#988COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF
#989Method for treating an inflammatory disease with compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
#990Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
#991Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
#992SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVES THEREOF AND HIGH-MONACOLIN K CONTENT RED YEAST RICE EXTRACT
#993Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism
#994RED YEAST RICE EXTRACT HIGH IN MONACOLIN K CONTENT
#995SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING EPA OR DERIVATIVES THEREOF, OPTIONALLY, DHA OR DERIVATIVES THEREOF AND MONACOLIN K
#996Compositions and soft tissue replacement methods
#997Compositions and soft tissue replacement methods
#998Pharmaceutical formulations containing lipoic acid derivatives
#999NUTRITIONAL PRODUCTS INCLUDING A NOVEL FAT SYSTEM INCLUDING FATTY ACIDS
#1000Use of conjugated linoleic acid
#1001Nutritional products including a novel fat system including monoglycerides
#1002Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
#1003Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
#1004RED YEAST RICE EXTRACT HIGH IN MONACOLIN K CONTENT
#1005Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
#1006Nutritional products including monoglycerides and fatty acids
#1007SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING EPA OR DERIVATIVES THEREOF, OPTIONALLY, DHA OR DERIVATIVES THEREOF AND MONACOLIN K
#1008SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVES THEREOF AND HIGH-MONACOLIN K CONTENT RED YEAST RICE EXTRACT
#1009Composition and Method for Prevention, Mitigation or Treatment of an Enteropathogenic Bacterial Infection
#1010BIOCOMPATIBLE TEA TREE OIL COMPOSITIONS
#1011METHODS AND COMPOSITIONS FOR INDUCING PHYSIOLOGICAL HYPERTROPHY
#1012Method For Increasing The Solubility Of Methionine By Mineral Addition And Acid Treatment
#1013Nutrition with lipids and non-digestible saccharides
#1014Compounds, compositions and methods useful for cholesterol mobilisation
#1015Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
#1016Infant nutritional compositions for preventing obesity
#1017Antimicrobial Compositions
#1018Method for Increasing the Production of a Specific ACYL-Chain Dihydroceramide(s) for Improving the Effectiveness of Cancer Treatments
#1019METHODS FOR PREPARING PROBIOTIC NANOPARTICLES
#1020METHOD FOR TREATING OR AMELIORATING MUCOCUTANEOUS OR OCULAR TOXICITIES
#1021TRANSDERMAL RICINOLEIC ACID COMPOSITIONS
#1022Ophthalmic composition
#1023Use of derivatives of polyunsaturated fatty acids as medicaments
#1024PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING RESPIRATORY TRACT INFECTIONS
#1025Methods and compositions for inducing physiological hypertrophy
#1026FATTY ACID ANALOGUES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISORDERS
#1027Lipid-containing compositions and methods of use thereof
#1028COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
#1029Therapy for MLL-rearranged leukemia
#1030Methods of treatment using anti-IL-20 antibodies
#1031Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
#1032Satiety-inducing composition
#1033Thermally Stable Oil-in-Water Emulsions Containing an Oil That Contains Polyunsaturated Fatty Acids
#1034Composition for improving membrane composition and functioning of cells
#1035Methods and Kits for Preventing the Spread of Sexually Transmitted Microorganisms
#1036DOCOSAHEXAENOIC ACID FOR THE TREATMENT OF HEART FAILURE
#1037Methods and compositions for improving cognitive function
#1038LAURIC ACID DISTILLATE FOR ANIMAL FEED
#1039Composition and method for control of diabetes
#1040Liposome compositions and methods of use thereof
#1041Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
#1042PKC activators and anticoagulant in regimen for treating stroke
#1043Composition for regulating lipid metabolism
#1044PHARMACEUTICAL COMPOSITIONS CONTAINING FLUORINATED OR PERFLUORINATED CARBOXYLIC ACIDS
#1045COMPOSITIONS COMPRISING MYRISTIC ACID AND USES THEREOF
#1046Azelaic acid-comprising formulation with added pigment
#1047FATTY ACID PROTEIN KINASE C ACTIVATORS AND ANTICOAGULANT FOR THE TREATMENT OF STROKE
#1048DAG-TYPE AND INDIRECT PROTEIN KINASE C ACTIVATORS AND ANTICOAGULANT FOR THE TREATMENT OF STROKE
#1049Enhanced Natural Colors
#1050Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
#1051VALPROIC ACID, DERIVATIVES, ANALOGUES, AND COMPOSITIONS INCLUDING SAME AND METHODS FOR THEIR THERAPEUTIC USE
#1052Absorption Enhancement of Statins and Omega Fatty Acids
#1053Cosmetic compositions
#1054Transdermal venous access locking solutions
#1055Family of pain producing substances and methods to produce novel analgesic drugs
#1056Krill Extracts for Treatment of Cardiovascular Diseases
#1057METHOD OF ADMINISTERING OPHTHALMIC FLUIDS
#1058Nutritional compositions with coated lipid globules
#1059NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE
#1060SYSTEMS AND METHODS FOR ENHANCING VACCINE EFFICACY
#1061NOVEL STATIN PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF TREATMENT
#1062Rapid release mini-tablets provide analgesia in laboratory animals
#1063METHODS FOR INCREASING ENDOGENOUS PLASMALOGEN LEVELS
#1064Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
#1065Antiinfective free intramammary veterinary composition
#1066Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes)
#1067Use of drugs that activate P2Y receptors to enhance synaptogenesis
#1068Topical compositions containing nitro fatty acids
#1069Skin patch for improving menstrual
#1070Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, stearic acid, magnesium sulfate, zinc oxide, glycerin, and water
#1071Compositions containing a capillary-active system with application-relevant diffferentiability and their use
#1072Method of treating inflammation with statins
#1073NUTRITIONAL COMPOSITION FOR WOUND HEALING
#1074NUTRITIONAL SUPPORT OF THE IMMUNE SYSTEM DURING ANTI-CANCER TREATMENT
#1075NUTRITIONAL SUPPORT TO PREVENT OR MODERATE BONE MARROW PARALYSIS OR NEUTROPENIA DURING ANTI-CANCER TREATMENT
#1076Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
#1077COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#1078Fatty acid C16: 1N7-palmitoleate a lipokine and biomarker for metabolic status
#1079DERMAL DELIVERY
#1080Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
#1081Oil and liquid silicone foamable carriers and formulations
#1082CHEMICALLY MODIFIED CELL-PENETRATING PEPTIDES FOR IMPROVED DELIVERY OF GENE MODULATING COMPOUNDS
#1083Method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis
#1084Compositions for treating rosacea
#1085Anaplerotic Therapy for Alzheimer's Disease and the Aging Brain
#1086Atherosclerotic Plaque Dissolution Composition
#1087Compositions and methods for influencing satiety, lipid metabolism, and fat utilization
#1088Compositions and methods for treating inflammatory disorders
#1089COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
#1090Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#1091Custom-formulated phospholipid microbubbles and methods and uses thereof
#1092Topical scar treatment composition
#1093BALANCED MYRISTATE- AND LAURATE-CONTAINING EDIBLE OIL
#1094GASTRIC THERAPIES AND COMPOSITIONS THEREFOR
#1095COMPOSITIONS COMPRISING AVERMECTIN/AZELAIC ACID COMPOUNDS USEFUL FOR TREATING, E.G., ROSACEA
#1096USE OF ALKANEDICARBOXYLIC ACIDS AND RETINOIDS FOR TREATMENT OF ROSACEA AND OTHER INFLAMMATORY SKIN DISEASES
#1097Products and Methods for Reducing Malodor from the Pudendum
#1098Pheromone compositions and methods of use
#1099HERNIA PATCH
#1100Bruise amelioration composition and method of use
#1101Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
#1102Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent
#1103COMPOSITIONS AND METHODS FOR ORAL DRUG DELIVERY
#1104Bruise amelioration composition and method of use
#1105Methods of modulating inflammation in preterm infants using carotenoids
#1106INFANT NUTRITIONAL COMPOSITIONS FOR PREVENTING OBESITY
#1107Nutritional Supplement For Patients With Chronic Heart Failure
#1108Superparamagnetic nanoparticles IN MEDICAL THERAPEUTICS and manufacturing method THEREOF
#1109Methods and Nutritional Formulations to Increase the Efficacy and Reduce the Side Effects of Cancer Treatment
#1110Topical compositions and methods for epithelial-related conditions
#1111Sprayable beautifying composition
#1112Alleviating oxidative stress disorders with PUFA derivatives
#1113COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK
#1114PROPHYLACTIC/AMELIORATING OR THERAPEUTIC AGENT FOR NON-ALCOHOLIC STEATOHEPATITIS
#1115Cosmetic composition and method for retarding hair growth
#1116Functionalization of Micro- and Nano-Particles for Selective Attachment to Calcium Biomineral Surfaces
#1117HUMAN BETA3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME
#1118Type a gelatin capsule containing PUFA in free acid form
#1119Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#1120USING INHIBITORS OF HISTONE DEACETYLASES FOR THE SUPPRESSION THERAPY OF INHERITED DISEASE PREDISPOSING CONDITIONS
#1121Methods for Treating Traumatic Brain Injury
#11225,6,7-TRIHYDROXYHEPTANOIC ACID AND ANALOGS FOR THE TREATMENT OF OCULAR DISEASES AND DISEASES ASSOCIATED WITH HYPERPROLIFERATIVE AND ANGIOGENIC RESPONSES
#1123Methods of administering a mixture of fatty acids for the treatment of non-human mammals
#1124Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
#1125Chemosensory receptor ligand-based therapies
#1126DOPAMINERGIC MIMETICS
#1127THERAPEUTIC INTERVENTION TO MIMIC THE EFFECT OF CALORIC RESTRICTION
#1128Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH
#1129Strontium compound for treatment of sub-dermal soft tissue pain
#1130Compositions against alkyl-acyl GPC, the derivatives and products thereof
#1131Fatty acid fractionation process, fatty acid products and use thereof
#1132METHODS FOR THE PREPARATION AND USE OF AQUEOUS SOLUTIONS OF MAGNESIUM VALPROATE HYDRATE AND L-CARNITINE
#1133METHODS OF TREATING NEUROLOGICAL DISEASES USING DOCOSAHEXAENOIC ACID AND ARACHIDONIC ACID COMPOSITIONS
#1134HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES
#1135METHOD FOR THE TREATMENT OF PSYCHIC DISORDERS
#1136Lipoxin A4 Protection for Retinal Cells
#1137TOPICAL COMPOSITION CONTAINING THE COMBINATION OF MUPIROCIN AND BECLOMETHASONE
#1138USE OF CIS-EPOXYEICOSANTRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO REDUCE PULMONARY INFILTRATION BY NEUTROPHILS
#1139Nutritive compositions and methods of using same
#1140COMPOSITION AND METHOD FOR TREATING ACNE
#1141Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
#1142Preparation for the prevention and/or treatment of vascular disorders
#1143Branched chain fatty acids for prevention or treatment of gastrointestinal disorders
#1144PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME
#1145PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME
#1146COMPOSITIONS AND METHODS FOR ENHANCING COGNITIVE FUNCTION
#1147Inflammatory Disease Treatment
#1148Atherosclerotic Plaque Dissolution Composition
#1149Compositions for the treatment of hoof diseases
#1150Medium-chain length fatty acids and glycerides as nephroprotection agents
#1151USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS
#1152Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
#1153ADJUNCTIVE FORMULATION AND METHODS FOR PALLIATION OF FINE WRINKLES, MOTTLED HYPERPIGMENTATION, TACTILE ROUGHNESS OF FACIAL SKIN AND RELATED DISORDERS
#1154Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
#1155COMPOSITIONS AND METHODS FOR PREVENTING AND MONITORING DISEASE
#1156Method for treating macular degeneration
#1157PHARMACEUTICAL COMPOSITION COMPRISING PEROXIDED OIL AND CHOLESTEROL AND USES THEREOF IN MEDICAL FIELD
#1158Chemosensory receptor ligand-based therapies
#1159Methods and compositions for the prevention and treatment of inflammatory diseases
#1160Abuse-deterrent drug formulations
#1161Transdermal venous access locking solution
#1162HSP90 Inhibitors of Protein-Protein Interaction HSP90 Chaperone Complexes and Therapeutic Uses Thereof
#1163COSMETIC FORMULATION TO TREAT ROSACEA TELANGIECTASIA
#1164Solid oral dosage form containing an enhancer
#1165Methods
#1166COMBINATION THERAPY, COMPOSITION AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS
#1167Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
#1168Compositions comprising A C2-C14 carboxylic acid and a surfactant for treating hoof diseases
#1169Antimicrobial Compositions And Related Methods
#1170COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS
#1171Method and composition for treatment of yeast infection through a radial appliance or a wet-cell battery appliance and solution jar set
#1172Fatty-acid based particles
#1173Fatty Acid Nutritional Supplement
#1174Nitrated-fatty acids modulation of type II diabetes
#1175Antimicrobial and antiviral composition
#1176THERAPEUTIC COMPOSITION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVE THEREOF, RESVERATROL AND GREEN TEA
#1177Compositions and methods of use
#1178INTRALUMINAL DEVICE WITH A COATING CONTAINING A THERAPEUTIC AGENT
#1179AGENT HAVING NEUROTROPHIC FACTOR-LIKE ACTIVITY
#1180NUTRACEUTICAL CO-CRYSTAL COMPOSITIONS
#1181METHODS OF TREATING PSYCHIATRIC, SUBSTANCE ABUSE, AND OTHER DISORDERS USING COMBINATIONS CONTAINING OMEGA-3 FATTY ACIDS
#1182Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
#1183Pharmaceutical formulations containing lipoic acid derivatives
#1184Cachexia prevention supplement
#1185Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
#1186Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly
#1187USE OF AGENTS THAT DOWN-REGULATE EXPRESSION OF TANIS AND/OR P21 Waf1/Cip1/Sd1 GENES, AND USE OF AGENTS THAT INHIBIT, DEGRADE, SEQUESTER OR PREVENT THE NEUROTOXICITY OF GENE PRODUCT PROTEINS OF TANIS AND P21 Waf1/Cip1/Sd1 GENES
#1188Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering from diseases caused by the monoaminooxidase excessive activity
#1189BARRIER INTEGRITY IN HIV PATIENTS
#1190Methods for reducing the incidence of mastitis
#1191USE OF BOSWELLIC ACID AND ITS DERIVATIVES FOR INHIBITING NORMAL AND INCREASED LEUCOCYTIC ELASTASE OR PLASMIN ACTIVITY
#1192COMPOSITION OF N-3 FATTY ACIDS HAVING HIGH CONCENTRATION OF EPA AND/OR DHA AND CONTAINING N-6 FATTY ACIDS
#1193METHOD OF TREATING VASCULAR INJURIES INDUCED BY AN EXCESS OF PLASMA LIPIDS USING COMBINATIONS OF VASOPROTECTIVE AGENTS
#1194AGENT AND METHOD FOR STABILIZING MEMBRANE PROTEIN
#1195Nutritive compositions and methods of using same
#1196COMPOSITIONS AND METHODS FOR REDUCING TRIGLYCERIDE LEVELS
#1197SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING RED YEAST RICE EXTRACT AND OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVE THEREOF
#1198AMPHIPATHIC CARBOXYLATES FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS
#1199Fatty acids for use as a medicament
#1200Compositions, methods, and kits for polyunsaturated fatty acids from microalgae